Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Fibromyalgia Syndrome (FMS) is a disorder of chronic, generalized muscular pain, accompanied by sleep disturbances, fatigue and cognitive dysfunction. There is no definitive pathogenesis except for altered central pain pathways. We previously reported increased serum levels of the neuropeptides substance P (SP) and its structural analogue hemokinin-1 (HK-1) together with the pro-inflammatory cytokines IL-6 and TNF in FMS patients as compared to sedentary controls. We hypothesize that thalamic mast cells contribute to inflammation and pain, by releasing neuro-sensitizing molecules that include histamine, IL-1β, IL-6 and TNF, as well as calcitonin-gene related peptide (CGRP), HK-1 and SP. These molecules could either stimulate thalamic nociceptive neurons directly, or via stimulation of microglia in the diencephalon. As a result, inhibiting mast cell stimulation could be used as a novel approach for reducing pain and the symptoms of FMS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Central sensitization: implications for the diagnosis and treatment of pain
Woolf, C. J. (2011) · Pain · doi:10.1016/j.pain.2010.09.030 · Cited by 4,771
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149
The development of allergic inflammation
Galli, S. J., Tsai, M., & Piliponsky, A. M. (2008) · Nature · doi:10.1038/nature07204 · Cited by 1,839
Fibromyalgia: A Clinical Review
Clauw, D. J. (2014) · JAMA · doi:10.1001/jama.2014.3266 · Cited by 1,674 · cited 2×
“…generalized fatigue, sleep abnormalities, (Clauw et al., 2011; Schmidt-Wilcke and Clauw, 2011; Clauw, 2014) and cognitive problems (Theoharides et al., 2015b; Hauser et al., 2019) assessed by the FSQ (Ferrari and Russell, 2013), which has about 93% sensitivity and 92% specificity (Clauw, 2014).”
MethodGalli, S. J., Borregaard, N., & Wynn, T. A. (2011) · Nature Immunology · doi:10.1038/ni.2109 · Cited by 1,055
Innate immunity in the central nervous system
Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034
Microglia: Scapegoat, saboteur, or something else?
Aguzzi, A., Barres, B. A., & Bennett, M. L. (2013) · Science · doi:10.1126/science.1227901 · Cited by 836
Fibromyalgia and overlapping disorders: The unifying concept of central sensitivity syndromes
Yunus, M. B. (2007) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.12.009 · Cited by 780
Cited by
Krock, E., Morado-Urbina, C. E., Menezes, J., Hunt, M. A., Sandström, A., Kadetoff, D., Tour, J., Verma, V., Kultima, K., Haglund, L., et al. (2023) · Pain · doi:10.1097/j.pain.0000000000002881 · Cited by 84
Animal models of fibromyalgia: What is the best choice?
Brum, E. S., Becker, G., Fialho, M. F. P., & Oliveira, S. M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107959 · Cited by 71
D’Amico, R., Fusco, R., Siracusa, R., Impellizzeri, D., Peritore, A. F., Gugliandolo, E., Interdonato, L., Sforza, A. M., Crupi, R., Cuzzocrea, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126471 · Cited by 51
T Cell Subpopulations in the Physiopathology of Fibromyalgia: Evidence and Perspectives
Banfi, G., Diani, M., Pigatto, P. D., & Reali, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041186 · Cited by 46
Grant, S., Norton, S., Weiland, R. F., Scheeren, A. M., Begeer, S., & Hoekstra, R. A. (2022) · Molecular Autism · doi:10.1186/s13229-022-00486-6 · Cited by 45
Fairweather, D., Bruno, K. A., Darakjian, A. A., Bruce, B. K., Gehin, J. M., Kotha, A., Jain, A., Peng, Z., Hodge, D. O., Rozen, T. D., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1096180 · Cited by 37
“, IBS, migraine) that directly influence pain and nerve function [reviewed in Meade and Garvey (40)], providing a physical rather than purely psychological explanation for symptoms (40, 44).”
BackgroundCould the fibromyalgia syndrome be triggered or enhanced by COVID-19?
Fialho, M. F. P., Brum, E. S., & Oliveira, S. M. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01160-w · Cited by 33
Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy
Novak, P., Giannetti, M. P., Weller, E., Hamilton, M. J., & Castells, M. (2022) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2021.10.006 · Cited by 32
Fineschi, S., Klar, J., Gustafsson, K. A., Jonsson, K., Karlsson, B., & Dahl, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.874490 · Cited by 31
Cordaro, M., Siracusa, R., D’Amico, R., Genovese, T., Franco, G., Marino, Y., Di Paola, D., Cuzzocrea, S., Impellizzeri, D., Di Paola, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116139 · Cited by 29
RetractedGonzález-Álvarez, M. E., Riquelme-Aguado, V., González-Pérez, Á., Murillo-Llergo, R., Manjón-Olmedillas, M., Turroni, S., Rossettini, G., & Villafañe, J. H. (2024) · Cells · doi:10.3390/cells13201719 · Cited by 20
Restless legs syndrome is associated with mast cell activation syndrome
Weinstock, L. B., Walters, A. S., Brook, J. B., Kaleem, Z., Afrin, L. B., & Molderings, G. J. (2020) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.8216 · Cited by 19
Involvement of peripheral mast cells in a fibromyalgia model in mice
Brum, E. D. S., Fialho, M. F. P., Becker, G., Nogueira, C. W., & Oliveira, S. M. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176385 · Cited by 11
Brum, E. S., Landini, L., Souza Monteiro de Araújo, D., Marini, M., Geppetti, P., Nassini, R., De Logu, F., & Oliveira, S. M. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.01.040 · Cited by 8
Almirall, M., Espartal, E., Michelena, X., Suso-Ribera, C., Serrat, M., Marsal, S., & Erra, A. (2025) · Biomedicines · doi:10.3390/biomedicines13061497 · Cited by 5
“This involvement of the immune system, together with other previous data on the existence of neuroinflammatory phenomena [16,17], could explain the increase in the NLR, a biomarker of systemic inflammation [4–6], compared with healthy controls and its relationship with disease activity observed in…”
Metadata
- Authors
- Theoharides, T. C., Tsilioni, I., & Bawazeer, M.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-08-02
- Volume
- 13
- Pages
- 353-353
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2959356991
- Cited by
- 148
- References
- 26
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.